1. Hôpital Saint Louis, Institut Universitaire d’Hématologie, University Paris Diderot, Paris, France;
2. Peter MacCallum Cancer Centre, East Melbourne, Australia, and University of Melbourne, Parkville, Australia;
3. Wroclaw Medical University, Wroclaw, Poland;
4. Medical University of Lodz, Lodz, Poland;
5. Algemeen Ziekenhuis Sint-Jan, Brugge, Belgium;
6. Samsung Medical Center, Seoul, Republic of Korea;
7. Cancer Care Manitoba, Winnipeg, Canada;
8. Barts Health National Health Service Trust, London, United Kingdom;
9. Princess Margaret Cancer Centre, Toronto, Canada;
10. Azienda Ospedaliero Universitaria S. Maria della Misericordia di Udine, Udine, Italy;
11. Centre Hospitalier Universitaire de Toulouse, Toulouse, France;
12. University of Alberta Hospital, Edmonton, Canada;
13. Hospital Central de Asturias, Oviedo, Spain;
14. Universitätsklinikum Leipzig, Leipzig, Germany;
15. Institute of Hematology and Medical Oncology “L. e A. Seràgnoli,” Bologna, Italy;
16. Hospital Universitario Virgen del Rocio/Instituto de BioMedicinia de Sevilla, Sevilla, Spain;
17. Universitätsklinikum Essen Klinik für Hämatologie, Essen, Germany;
18. Dana-Farber Cancer Institute, Boston, MA;
19. Celgene Corporation, Summit, NJ; and
20. Universitätsklinikum Ulm, Ulm, Germany